https://www.selleckchem.com/pr....oducts/pha-848125.ht
1±22.9mm (P=1. and 47.3±28.2mm (P=0.001) for INO, 1% lidocaine and no analgesic, respectively. No adverse events were reported in 91 (86.7%) patients in the INO group compared with 79 (76%) in the 1%-lidocaine group (P=0.04) and 85 (81%) in the no-analgesic group (P=0.26). INO was as effective as 1% lidocaine in pain control for in-office hysteroscopy and was better tolerated. The no-analgesic group presented the poorer results, so was the least recommended clinical option. INO was as effective as 1% lidocaine in pain control for i
Like
Comment
Share
